Patent · US Active

Compositions and methods for inhibition of the JAK pathway

US8193197B2 · kind B2 · utility

16Cited by
6References
38Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 19, 2007
Grant dateJun 5, 2012
Priority date
Expiry dateFeb 24, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D498/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention encompasses compounds having formula I and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases are therapeutically useful.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.